Estrogen receptor expression in sporadic vestibular schwannomas
- PMID: 21099731
- PMCID: PMC3073320
- DOI: 10.1097/MAO.0b013e3181feb92a
Estrogen receptor expression in sporadic vestibular schwannomas
Abstract
Hypothesis: We hypothesize that vestibular schwannomas (VSs) exhibit up-regulation of estrogen receptor (ER) at the protein level compared with control great auricular nerve (GAN).
Background: It has been reported in the literature that VS occur more commonly in women and tend to be larger and more vascular in women, and growth rate can accelerate during pregnancy. The literature contains widely divergent results on ER expression in VS, however, varying from no detectable levels to detection of ER in all samples.
Methods: Sixteen sporadic VS specimens were immediately snap-frozen after microsurgical excision and analyzed for phosphorylated and total levels of ERα with Western blot analysis. ERα expression levels were normalized to actin; then, relative expression to GAN was determined.
Results: All VS specimens exhibited expression of both phosphorylated and total ERα. Total ERα expression in VS is equivalent to or slightly up-regulated compared with GAN. VS specimens exhibited more pronounced up-regulation of phosphorylated (i.e., activated) levels of ERα compared with GAN.
Conclusion: We have demonstrated that ERα expression in VS is equivalent to GAN. The phosphorylated form of the receptor is up-regulated compared with GAN, however, indicating a higher level of ERα activation in sporadic VS compared with normal nerve. Further investigation into antiestrogen therapy for VS is warranted.
Figures



Similar articles
-
Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.Laryngoscope. 2008 Aug;118(8):1458-63. doi: 10.1097/MLG.0b013e318177e20b. Laryngoscope. 2008. PMID: 18670322 Free PMC article.
-
Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.World J Gastroenterol. 2017 Oct 7;23(37):6802-6816. doi: 10.3748/wjg.v23.i37.6802. World J Gastroenterol. 2017. PMID: 29085224 Free PMC article.
-
Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation.Otol Neurotol. 2004 Mar;25(2):155-9. doi: 10.1097/00129492-200403000-00013. Otol Neurotol. 2004. PMID: 15021776
-
CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.Otol Neurotol. 2020 Jan;41(1):e94-e102. doi: 10.1097/MAO.0000000000002430. Otol Neurotol. 2020. PMID: 31789805
-
The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):90-5. doi: 10.1016/j.jsbmb.2009.01.017. Epub 2009 Feb 6. J Steroid Biochem Mol Biol. 2009. PMID: 19429437 Review.
Cited by
-
Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge.GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017 Dec 18;16:Doc03. doi: 10.3205/cto000142. eCollection 2017. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017. PMID: 29279723 Free PMC article. Review.
-
Angiotensin-Receptor Blockers Prevent Vestibular Schwannoma-Associated Hearing Loss.Otol Neurotol. 2025 Feb 1;46(2):183-189. doi: 10.1097/MAO.0000000000004376. Otol Neurotol. 2025. PMID: 39792982 Free PMC article.
-
A Unified Methodological Framework for Vestibular Schwannoma Research.J Vis Exp. 2017 Jun 20;(124):55827. doi: 10.3791/55827. J Vis Exp. 2017. PMID: 28654042 Free PMC article.
-
Progression of Contralateral Hearing Loss in Patients With Sporadic Vestibular Schwannoma.Front Neurol. 2020 Aug 14;11:796. doi: 10.3389/fneur.2020.00796. eCollection 2020. Front Neurol. 2020. PMID: 33013614 Free PMC article.
-
Large Vestibular Schwannomas Presenting during Pregnancy: Management Strategies.J Neurol Surg B Skull Base. 2014 Jun;75(3):214-20. doi: 10.1055/s-0034-1370784. Epub 2014 Apr 4. J Neurol Surg B Skull Base. 2014. PMID: 25072015 Free PMC article.
References
-
- Evans DG, Moran A, King A, et al. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005;26:93–7. - PubMed
-
- Abaza MM, Makariou E, Armstrong M, Lalwani A. Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope. 1996;106:694–8. - PubMed
-
- Jeyakumar A, Seth R, Brickman TM, et al. The prevalence and clinical course of patients with ‘incidental’ acoustic neuromas. Acta oto-laryngol. 2007;127:1051–7. - PubMed
-
- Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Quart J Med. 1992;84:603–18. - PubMed
-
- Evans DG. Neurofibromatosis type 2: genetic and clinic features. ENT J. 1999;78:97–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical